AAAAAA

   
Results: 1-3 |
Results: 3
Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture
Authors: Junquero, D Pilon, A Carilla-Durand, E Patoiseau, JF Tarayre, JP Torpier, G Staels, B Fruchart, JC Colpaert, FC Clavey, V Delhon, A
Citation: D. Junquero et al., Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture, BIOCH PHARM, 61(4), 2001, pp. 387-398
Pharmacological profile of F 12511, (S)-2 ',3 ',5 '-trimethyl-4 '-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor
Authors: Junquero, D Oms, P Carilla-Durand, E Autin, JM Tarayre, JP Degryse, AD Patoiseau, JF Colpaert, FC Delhon, A
Citation: D. Junquero et al., Pharmacological profile of F 12511, (S)-2 ',3 ',5 '-trimethyl-4 '-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor, BIOCH PHARM, 61(1), 2001, pp. 97-108
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine
Authors: John, GW Pauwels, PJ Perez, M Halazy, S Le Grand, B Verscheure, Y Valentin, JP Palmier, C Wurch, T Chopin, P Marien, M Kleven, MS Koek, W Assie, MB Carilla-Durand, E Tarayre, JP Colpaert, FC
Citation: Gw. John et al., F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine, J PHARM EXP, 290(1), 1999, pp. 83-95
Risultati: 1-3 |